Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Net Income towards Common Stockholders: 2020-2025

Historic Net Income towards Common Stockholders for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -$6.6 million.

  • Biofrontera's Net Income towards Common Stockholders fell 17.29% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year decrease of 36.89%. This contributed to the annual value of -$17.8 million for FY2024, which is 11.78% up from last year.
  • Latest data reveals that Biofrontera reported Net Income towards Common Stockholders of -$6.6 million as of Q3 2025, which was down 24.89% from -$5.3 million recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Net Income towards Common Stockholders registered a high of $5.6 million during Q1 2022, and its lowest value of -$16.0 million during Q3 2021.
  • Its 3-year average for Net Income towards Common Stockholders is -$4.9 million, with a median of -$5.7 million in 2024.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first skyrocketed by 257.36% in 2022, then crashed by 1,971.60% in 2025.
  • Quarterly analysis of 5 years shows Biofrontera's Net Income towards Common Stockholders stood at -$14.5 million in 2021, then surged by 80.80% to -$2.8 million in 2022, then soared by 226.61% to $3.5 million in 2023, then slumped by 139.59% to -$1.4 million in 2024, then declined by 17.29% to -$6.6 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$6.6 million for Q3 2025, versus -$5.3 million for Q2 2025 and -$4.2 million for Q1 2025.